Table 2

Treatments administered to study eyes through month 36 of RIDE and RISE, stratified by treatment arm (pooled data)

TreatmentSham (n=257)Ranibizumab 0.3 mg (n=250)Ranibizumab 0.5 mg (n=252)
Median number of ranibizumab injections113434
Macular laser treatment, n (%)188 (73.2)97 (38.8)74 (29.4)
Panretinal laser treatment, n (%)34 (13.2)4 (1.6)6 (2.4)